November 8, 2017 /
Teva Pharmaceuticals and Nonprofit Group Can Do MS Team Up to Offer Tools for Better Communication Between Women with MS and Their Healthcare Providers
November 08, 2017 08:00 AM Eastern Standard Time
FRAZER, Pa. and AVON, Colo.–(BUSINESS WIRE)–Approximately 400,000 people in the U.S. have Multiple sclerosis (MS), an unpredictable disease of the central nervous system that affects 2-3 times as many women as men. Onset is usually between the ages of 20-40, a time when many women are building their careers, personal lives and families. Women newly diagnosed with MS have significant concerns about how these parts of their lives could change, but a survey asking about personal relationships, reproductive issues and employment concerns shows 98% felt many of these concerns were not addressed by their healthcare team when first diagnosed.
The survey was conducted by Wakefield Research for Teva Pharmaceuticals among 1,000 women diagnosed with MS in the last 5 years. It also showed that 71% of respondents believed talking to their doctor earlier or more openly would have made the first six months after diagnosis easier. To empower women to take charge of their MS, Teva and Can Do MS have developed tools to help women and healthcare professionals engage right from the start about topics that matter to women.
These resources can be found at mscando.org/womenandms.
November 08, 2017 08:00 AM Eastern Standard Time
FRAZER, Pa. and AVON, Colo.–(BUSINESS WIRE)–Approximately 400,000 people in the U.S. have Multiple sclerosis (MS), an unpredictable disease of the central nervous system that affects 2-3 times as many women as men. Onset is usually between the ages of 20-40, a time when many women are building their careers, personal lives and families. Women newly diagnosed with MS have significant concerns about how these parts of their lives could change, but a survey asking about personal relationships, reproductive issues and employment concerns shows 98% felt many of these concerns were not addressed by their healthcare team when first diagnosed.
The survey was conducted by Wakefield Research for Teva Pharmaceuticals among 1,000 women diagnosed with MS in the last 5 years. It also showed that 71% of respondents believed talking to their doctor earlier or more openly would have made the first six months after diagnosis easier. To empower women to take charge of their MS, Teva and Can Do MS have developed tools to help women and healthcare professionals engage right from the start about topics that matter to women.
These resources can be found at mscando.org/womenandms.
The top reason women cited for not talking to a doctor or other healthcare professional about either their work, family planning or personal relationship concerns was that they aren’t comfortable talking about them. The new survey is an important examination of these areas and the concerns women face after diagnosis, including: ability to care for themselves (34%), ability to care for their current or future children (22%), career and work life demands (17%), ability to have children (15%) and personal relationships (13%).
MS Views and News provides beneficial Multiple Sclerosis education, information, resources and services.
…………………………………………………………………….
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
